We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+0.68%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$1.3B
(+35%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
24.66%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
2,392
New
516
Increased
636
Reduced
565
Closed
649
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$193M |
| 2 |
NVIDIA
NVDA
|
+$46.9M |
| 3 |
Broadcom
AVGO
|
+$38.4M |
| 4 |
Apple
AAPL
|
+$32.6M |
| 5 |
Amazon
AMZN
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$114M |
| 2 |
ProShares UltraPro Short QQQ
SQQQ
|
+$32.1M |
| 3 |
UnitedHealth
UNH
|
+$16.1M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$12.6M |
| 5 |
Zoetis
ZTS
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.56% |
| 2 | Healthcare | 10.35% |
| 3 | Consumer Discretionary | 10.27% |
| 4 | Industrials | 9.88% |
| 5 | Financials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Amylyx Pharmaceuticals
AMLX
$2.19B
| $33.6K | ﹤0.01% |
+17,685
| New | +$34.3K |
|
1677
Plug Power
PLUG
$2.65B
| $33.6K | ﹤0.01% |
14,400
-2,333
| -14% | -$6.68K |
|
1678
Gevo
GEVO
$353M
| $27.8K | ﹤0.01% |
+49,978
| New | +$33.5K |
|
1679
Veritone
VERI
$92.9M
| $27.4K | ﹤0.01% |
+12,113
| New | +$43K |
|
1680
Aclaris Therapeutics
ACRS
$715M
| $24.8K | ﹤0.01% |
+22,524
| New | +$26.5K |
|
1681
Karyopharm Therapeutics
KPTI
$155M
| $23.3K | ﹤0.01% |
+1,787
| New | +$29.6K |
|
1682
Butterfly Network
BFLY
$1.86B
| $22.7K | ﹤0.01% |
+27,011
| New | +$25.2K |
|
|
QVCGA
1683
DELISTED
QVC Group Inc Series A
QVCGA
| $22.1K | ﹤0.01% |
700
-7,939
| -92% | -$330K |
|
|
ASRT
1684
DELISTED
Assertio
ASRT
| $21.9K | ﹤0.01% |
+1,177
| New | +$17.5K |
|
1685
Babcock & Wilcox
BW
$1.18B
| $21.6K | ﹤0.01% |
+14,903
| New | +$17.9K |
|
|
LAZR
1686
DELISTED
Luminar Technologies
LAZR
| $21.3K | ﹤0.01% |
+953
| New | +$22.6K |
|
1687
Lumen
LUMN
$6.43B
| $21K | ﹤0.01% |
+19,097
| New | +$24.2K |
|
|
ME
1688
DELISTED
23andMe Holding Co
ME
| $20.7K | ﹤0.01% |
+2,648
| New | +$25.4K |
|
1689
PMV Pharmaceuticals
PMVP
$57.1M
| $19.2K | ﹤0.01% |
+11,873
| New | +$21.4K |
|
1690
Protalix BioTherapeutics
PLX
$183M
| $16.6K | ﹤0.01% |
+14,224
| New | +$16.8K |
|
1691
Citius Pharmaceuticals
CTXR
$15.6M
| $16.6K | ﹤0.01% |
+1,137
| New | +$20.4K |
|
|
MRNS
1692
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $15.6K | ﹤0.01% |
+13,334
| New | +$33.4K |
|
|
MAGN
1693
Magnera Corp
MAGN
$493M
| $15.5K | ﹤0.01% |
+856
| New | +$18.4K |
|
1694
Microvast
MVST
$237M
| $15.5K | ﹤0.01% |
+33,891
| New | +$15.2K |
|
|
ORGN
1695
DELISTED
Origin Materials
ORGN
| $15.1K | ﹤0.01% |
+557
| New | +$14.9K |
|
1696
Vuzix
VUZI
$178M
| $13.9K | ﹤0.01% |
+10,288
| New | +$14.2K |
|
|
KZR
1697
DELISTED
Kezar Life Sciences
KZR
| $13.6K | ﹤0.01% |
+2,263
| New | +$17.2K |
|
1698
American Well
AMWL
$180M
| $13.3K | ﹤0.01% |
+2,049
| New | +$20.6K |
|
|
OPTN
1699
DELISTED
OptiNose
OPTN
| $12.9K | ﹤0.01% |
+830
| New | +$13.9K |
|
|
KYNB
1700
Kyntra Bio
KYNB
$27.4M
| $12.9K | ﹤0.01% |
+580
| New | +$17.9K |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2024 Portfolio in Review
As of Q2 2024, Jump Financial held 2,392 positions worth $5B, up 35% from $3.71B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jump Financial deployed $1.23B of net new capital in Q2 2024, opening 516 new positions and adding to 636 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 127,626 shares worth $18.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $114M trimmed.
- Jump Financial's largest Q2 2024 buy was State Street Health Care Select Sector SPDR ETF: 127,626 shares worth $18.6M.
- Jump Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $193M increase.
- Jump Financial's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $114M.
- Jump Financial fully exited ProShares UltraPro Short QQQ in Q2 2024, selling an estimated $32.1M.
- Jump Financial's ten largest holdings make up 21% of its $5B portfolio in Q2 2024.
- Jump Financial opened 516 new positions and closed 649 in Q2 2024.
- Jump Financial's portfolio value rose 35% quarter-over-quarter to $5B.
Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.